RMD DMA
As of date:10/22/2020
RMD stock price:182.82
RMD 50 DMA:175.71
RMD 200 DMA:169.65
RMD MACD (200-50):-6.06

Also see:
RMD Market Cap History
RMD Shares Outstanding History
RMD YTD Return
RMD RSI
RMD MACD
RMD Technical Analysis

Vir Biotechnology (VIR) Shares Cross Below 200 DMA
1 hour, 1 minute ago


FNKO Crosses Above Key Moving Average Level
1 hour, 1 minute ago


CSOD Makes Bullish Cross Above Critical Moving Average
1 hour, 12 minutes ago


J&J Snack Foods (JJSF) Shares Cross Above 200 DMA
1 hour, 18 minutes ago


Cloudera Breaks Above 200-Day Moving Average - Bullish for CLDR
1 hour, 21 minutes ago


XEC Makes Bullish Cross Above Critical Moving Average
1 hour, 21 minutes ago


CAE Crosses Above Key Moving Average Level
1 hour, 21 minutes ago


IVC Crosses Below Key Moving Average Level
1 hour, 23 minutes ago


Manulife Financial (MFC) Shares Cross Above 200 DMA
1 hour, 23 minutes ago


CIA Makes Notable Cross Below Critical Moving Average
1 hour, 24 minutes ago


Robert Half International Breaks Below 200-Day Moving Average - Notable for RHI
1 hour, 26 minutes ago


Lakeland Bancorp (LBAI) Shares Cross Above 200 DMA
1 hour, 44 minutes ago


Civista Bancshares Breaks Above 200-Day Moving Average - Bullish for CIVB
1 hour, 45 minutes ago


CCNE Makes Bullish Cross Above Critical Moving Average
1 hour, 46 minutes ago


Alnylam Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ALNY
1 hour, 46 minutes ago


More Technical Analysis News

RMD DMARMD MACD
ResMed is a holding company. Through its operating subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software solutions that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Co.'s portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators and cloud-based software informatics solutions.

When researching a stock like ResMed, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from RMD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for RMD stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the RMD 200 day moving average ("RMD 200 DMA"), while one of the most popular "shorter look-backs" is the RMD 50 day moving average ("RMD 50 DMA"). A chart showing both of these popular moving averages is shown on this page for ResMed.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for RMD:
RMD SEC Filing Email Alerts ServiceExternal link
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ResMed (RMD) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

SYK DMA
TFX DMA
TMO DMA
UHS DMA
VAR DMA
VRTX DMA
WAT DMA
WCG DMA
XRAY DMA
ZBH DMA
More Healthcare companies »

 

RMD DMA | www.StockDMA.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.